CHG

508

-1.17%↓

CHG

508

-1.17%↓

CHG

508

-1.17%↓

CHG

508

-1.17%↓

CHG

508

-1.17%↓

Search

Halma PLC

Gesloten

SectorIndustrieën

3,874 -1.27

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3874

Max

3974

Belangrijke statistieken

By Trading Economics

Inkomsten

107M

187M

Verkoop

651M

1.2B

K/W

Sectorgemiddelde

42.528

47.18

EPS

0.553

Dividendrendement

0.61

Winstmarge

15.096

Werknemers

9,000

EBITDA

184M

317M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+1.57% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.61%

2.05%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

823M

15B

Vorige openingsprijs

3875.27

Vorige sluitingsprijs

3874

Nieuwssentiment

By Acuity

20%

80%

36 / 406 Rangschikking in Industrials

Halma PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 feb 2026, 23:47 UTC

Marktinformatie

Global Equities Roundup: Market Talk

19 feb 2026, 23:47 UTC

Marktinformatie

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

19 feb 2026, 23:39 UTC

Acquisities, Fusies, Overnames

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

19 feb 2026, 23:38 UTC

Winsten

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

19 feb 2026, 23:38 UTC

Winsten

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

19 feb 2026, 23:38 UTC

Winsten

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

19 feb 2026, 23:37 UTC

Marktinformatie

Gold Edges Lower on Possible Position Adjustment -- Market Talk

19 feb 2026, 23:34 UTC

Winsten

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

19 feb 2026, 23:34 UTC

Winsten

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

19 feb 2026, 23:33 UTC

Winsten

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

19 feb 2026, 23:33 UTC

Winsten

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

19 feb 2026, 22:13 UTC

Marktinformatie

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

19 feb 2026, 22:08 UTC

Winsten

Fairfax Financial 4Q Rev $8.11B >FFH.T

19 feb 2026, 22:07 UTC

Winsten

Eldorado Gold 4Q EPS $1.19 >ELD.T

19 feb 2026, 22:06 UTC

Winsten

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

19 feb 2026, 22:05 UTC

Winsten

Eldorado Gold 4Q Adj EPS 63c >ELD.T

19 feb 2026, 22:05 UTC

Winsten

Eldorado Gold 4Q Rev $577.2M >ELD.T

19 feb 2026, 22:04 UTC

Winsten

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

19 feb 2026, 22:04 UTC

Winsten

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

19 feb 2026, 21:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

19 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

19 feb 2026, 21:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

19 feb 2026, 21:43 UTC

Winsten

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

19 feb 2026, 21:42 UTC

Acquisities, Fusies, Overnames

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

19 feb 2026, 21:42 UTC

Winsten

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

19 feb 2026, 21:41 UTC

Winsten

Correct: St Barbara 1H Net Loss A$249,000

19 feb 2026, 21:40 UTC

Winsten

St Barbara 1H Net Loss A$249 Million

19 feb 2026, 21:39 UTC

Winsten

Perseus Mining Reaffirms FY26 Production, AISC Guidance

19 feb 2026, 21:37 UTC

Winsten

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

19 feb 2026, 21:37 UTC

Winsten

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Peer Vergelijking

Prijswijziging

Halma PLC Prognose

Koersdoel

By TipRanks

1.57% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 3,985.45 GBX  1.57%

Hoogste 4,280 GBX

Laagste 3,500 GBX

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Halma PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

6

Buy

5

Hold

0

Sell

Sentiment

By Acuity

36 / 406 Rangschikking in Industrieën

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat